Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study
Authors:
- Todd HulganTHTodd Hulgan
- David W HaasDHDavid W Haas
- Jonathan L HainesJHJonathan L Haines
- Marylyn D RitchieMRMarylyn D Ritchie
- Gregory K RobbinsGRGregory K Robbins
- Robert W ShaferRSRobert W Shafer
- David B CliffordDCDavid B Clifford
- Asha R KallianpurAKAsha R Kallianpur
- Marshall SummarMSMarshall Summar
- Jeffrey A CanterJCJeffrey A Canter
- 2 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (13) , 1341-1349
Abstract
HIV nucleoside reverse transcriptase inhibitors (NRTI) can cause peripheral neuropathy that is a result of mitochondrial injury. Polymorphisms in the mitochondrial genome define haplogroups that may have functional implications. The objective of this study was to determine if NRTI-associated peripheral neuropathy is associated with European mitochondrial haplogroups. Case–control study of Adult AIDS Clinical Trials Group (ACTG) study 384 and ACTG Human DNA Repository participants. ACTG study 384 was a treatment strategy trial of antiretroviral therapy with didanosine (ddI) plus stavudine (d4T) or zidovudine plus lamivudine given with efavirenz, nelfinavir, or both. Subjects were followed for up to 3 years. Peripheral neuropathy was ascertained based on signs and symptoms. For this analysis, polymorphisms that define European mitochondrial haplogroups were characterized in a majority of ACTG 384 participants, and associations with peripheral neuropathy were assessed using logistic regression. A total of 509 subjects were included in this analysis of whom 250 (49%) were self-identified as white, non-Hispanic. Mitochondrial haplogroup T was more frequent in subjects who developed peripheral neuropathy. Among 137 white subjects randomized to receive ddI plus d4T, 20.8% of those who developed peripheral neuropathy belonged to mitochondrial haplogroup T compared to 4.5% of control subjects (odds ratio, 5.4; 95% confidence interval, 1.4–25.1; P = 0.009). Independent predictors of peripheral neuropathy were randomization to receive ddI plus d4T, older age, and mitochondrial haplogroup T. A common European mitochondrial haplogroup may predict NRTI-associated peripheral neuropathy. Future studies should validate this relationship, and evaluate non-European mitochondrial haplogroups and other NRTI toxicities.Keywords
This publication has 42 references indexed in Scilit:
- Mitochondrial DNA polymorphisms as risk factors for Parkinson?s disease and Parkinson?s disease dementiaHuman Genetics, 2004
- A Multi-Investigator/Institutional DNA Bank for AIDS-Related Human Genetic Studies: AACTG Protocol A5128HIV Research & Clinical Practice, 2003
- Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virusEye, 2003
- Mitochondrial DNA polymorphisms associated with longevity in a Finnish populationHuman Genetics, 2003
- FK506 is neuroprotective in a model of antiretroviral toxic neuropathyAnnals of Neurology, 2002
- The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup JHuman Genetics, 2002
- A Comparision of Genetic Mitochondrial Disease and Nucleoside Analogue Toxicity: Does Fetal Nucleoside Toxicity Underlie Reports of Mitochondrial Disease in Infants Born to Women Treated for HIV Infection?Annals of the New York Academy of Sciences, 2000
- Late onset of Leber's hereditary optic neuropathy in HIV infectionBritish Journal of Ophthalmology, 1999
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Mitochondrial oxidative phosphorylation defects in Parkinson's diseaseAnnals of Neurology, 1992